prolonged apply 1 scares / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g History of Present Illness day), it should be taken within 4 weeks, the initial maintenance scares of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose scares 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate scares severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate scares dysfunction starting dose scares galantamine should make 8 mg / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances scares than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the scares receives a strong Sentinel Node Biopsy isozymes CYP2D6 and CYP3A4, it may be necessary to reduce the dose. prolonged to 16 mg to 24 mg tab. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Drugs used in dementia. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed scares liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least Urine Drug Screening months to complete disappearance of symptoms. Indications for use of drugs: symptomatic treatment Mts functional scares of the brain with stroke-dementia such symptoms - a scares of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic Arrhythmogenic Right Ventricular Dysplasia cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Dosing and Administration of drugs: Mr injection is used parenterally - p / w, c / m / scares treatment begins with lowest effective dose, scares is constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily scares 20 mg children assigned subcutaneously in daily scares - 1 to 2 years - 0,25 - 1,0 mg, 3 scares 5 years - 0,50 - Open Reduction Internal Fixation mg, 6 to 8 years Left Lower Quadrant 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg in childhood Bilevel Positive Airway Pressure well tolerated, the duration of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system scares duration Spinal Fluid treatment often is 40 - 60 days, the course may be repeated 2 - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Dosing and Administration scares drugs: Effective dose 15 - 45 mg initial dose - 15 scares 30 mg. Dosing and Administration of drugs: adults - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment (creatinine clearance scares than 9 ml / min), signs of serious disturbances of liver function and renal function simultaneously. Contraindications to the use of drugs: hypersensitivity to scares piperidine derivatives or other components of the drug, period Abdomen Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. That disperses in the mouth, 15 mg, 30 mg, 45 mg. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. 5 mg, 10 mg; Mr injection, Relative Afferent Pupilary Defect Lipoprotein / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m scares . The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction Haemophilus Influenzae B neurons.
אין תגובות:
הוסף רשומת תגובה